About
Envoy Medical Inc. (NASDAQ:COCH) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 22 2026
Envoy Medical Reaches Critical Milestone in Pivotal Clinical Trial of Fully Implanted Acclaim(R) Cochlear Implant
Apr 16 2026
Envoy Medical Appoints Chas McKhann to Board of Directors
Apr 1 2026
Envoy Medical Announces First Patients Successfully Reaching 12-Month Endpoint in Pivotal Clinical Trial for Fully Implanted Cochlear Implant
Mar 23 2026
Envoy Medical Reports Full Year 2025 Financial Results
Mar 11 2026
Envoy Medical Completes Enrollment of Pivotal Clinical Trial Evaluating First-Of-Its-Kind Fully Implanted Cochlear Implant
Financials
Revenue
$241 K
Market Cap
$54.2 M
EPS
-1.23
Translate